Ipamorelin 60mg — Vial Spec, Reconstitution Math & COA

Overview of Ipamorelin 60mg Vial Specifications

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2 and a molecular weight of approximately 711.85 g/mol. As a selective growth hormone secretagogue receptor (GHS-R1a) agonist, it has emerged as a critical reference compound across cellular and animal research models studying neuroendocrine signaling, somatotropic axis regulation, and tissue regeneration dynamics. A 60mg format provides a massive reservoir of active peptide, designed to accommodate automated liquid handlers and large-volume assay series.

When purchasing high-mass configurations, maintaining strict analytical verification is paramount. Minor variances in batch purity can significantly skew experimental outcomes in sensitive bioassays. PX1 Research ensures that all research compounds undergo comprehensive analytical characterization, allowing researchers to evaluate compound integrity before introducing reagents to culture systems or animal models. To browse our complete catalog of analytical-grade compounds, visit our all peptides directory.

Preclinical Mechanism of Action: Selective GHS-R1a Activation

In preclinical research models, ipamorelin functions by binding to the GHS-R1a receptor on anterior pituitary somatotrope cells and hypothalamic neurons. Unlike non-selective ghrelin mimetics, in vitro receptor binding assays demonstrate that ipamorelin stimulates growth hormone (GH) release via a signal transduction pathway involving intracellular calcium mobilization without triggering significant co-secretion of adrenocorticotropic hormone (ACTH) or prolactin.

Comparative endocrinology studies in rodent models highlight that ipamorelin maintains a tight, pulsatile secretion profile mimicking physiological GH release patterns. This specificity makes it a primary tool for isolated somatotropic evaluation. Because it does not stimulate cortisol or aldosterone pathways in animal subjects, researchers can evaluate anabolic signaling, nitrogen retention, and bone mineral density shifts without confounding stress-axis variables. For a broader overview of secretagogue pathways, review our research library hub.

Reconstitution Mathematics for 60mg Lyophilized Vials

Reconstituting a 60mg vial requires precise liquid handling due to the high mass of peptide cake. Researchers must calculate final volumetric concentration based on the desired working aliquot volume and dosing precision required for downstream assays. Using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory-grade saline, the following concentration values apply when mixing a 60mg (60,000 mcg) vial:

1.0 mL Diluent Addition: Yields a concentration of 60 mg/mL (60,000 mcg/mL, or 60 mcg/µL). This hyper-concentrated stock is ideal for primary aliquot stock plates but may present higher solution viscosity.

2.0 mL Diluent Addition: Yields a concentration of 30 mg/mL (30,000 mcg/mL, or 30 mcg/µL). At this ratio, a standard 100-unit laboratory syringe (1.0 mL total volume) contains 30 mg total, where each 1-unit graduation (0.01 mL) equals 300 mcg of active peptide.

3.0 mL Diluent Addition: Yields a concentration of 20 mg/mL (20,000 mcg/mL, or 20 mcg/µL). At 20 mg/mL, each 1-unit graduation (0.01 mL) represents 200 mcg. This dilution provides optimal volumetric accuracy for micro-dosing protocols in small animal models.

For custom concentration calculations or multi-vial adjustments, utilize our interactive reconstitution calculator to verify laboratory math before fluid addition.

Aliquot Management and Solubilization Protocol

To solubilize a 60mg lyophilized cake, inject the chosen volume of diluent slowly along the glass inner wall of the vial. Avoid direct high-pressure stream impingement onto the freeze-dried powder to prevent peptide denaturation or excessive bubble formation. Gently swirl the vial in a circular motion until the solution clears completely. Never shake or vortex peptide solutions.

Because a 60mg vial contains a high quantity of material, repeated needle punctures into a single stopper risk rubber coring and bacterial contamination. Institutional protocols dictate drawing the stock solution immediately after complete solubilization and distributing it into sterile, single-use polypropylene micro-centrifuge tubes (aliquots). Storage of working aliquots at -20°C or -80°C prevents degradation associated with repeated freeze-thaw cycles.

Analytical Verification: HPLC, MS, and Endotoxin Testing

High-mass peptide fills require rigorous analytical validation to confirm chemical identity and purity. PX1 Research subjects every production lot to High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) in ISO 17025 accredited testing facilities. HPLC analysis confirms chemical purity exceeding 99.0%, while MS verifies exact monoisotopic mass alignment with theoretical ipamorelin values.

Furthermore, because high-volume vials are frequently deployed in cell culture or animal research, endotoxin testing (LAL assay) is conducted on every batch. High endotoxin levels can induce non-specific inflammatory responses in vitro or pyrogenic reactions in animal models, corrupting experimental data. Researchers can view and download lot-matched documentation directly from our COA portal.

Comparative Analysis: Ipamorelin vs. GHRP-2, GHRP-6, and CJC-1295

When designing somatotropic research frameworks, investigators frequently compare ipamorelin against other growth hormone secretagogues. Older generation hexapeptides such as GHRP-6 and GHRP-2 display potent GH release capability in preclinical studies but also trigger marked increases in serum cortisol and prolactin, alongside significant appetite stimulation via ghrelin-mediated hypothalamic networks. In contrast, ipamorelin provides targeted GHS-R1a activation without collateral endocrine disruption.

When synergistic GH pulses are required in animal study designs, ipamorelin is often evaluated alongside GHRH mimetics like CJC-1295 No DAC. While ipamorelin initiates the calcium-dependent secretory pulse at the pituitary level, GHRH mimetics amplify cyclic AMP pathways, resulting in a dual-mechanism secretagogue response that yields greater total GH amplitude than either compound administered in isolation.

Optimal Storage and Stability Parameters

Lyophilized ipamorelin 60mg vials are highly stable when stored under controlled environment conditions. Sealed vials should be stored at -20°C for short-to-medium term storage (up to 12 months) or -80°C for long-term preservation. Exposure to direct light, ambient room temperature, and moisture ingress accelerates peptide chain hydrolysis and oxidation.

Once reconstituted with bacteriostatic water, the liquid solution must be refrigerated at 2°C to 8°C and utilized within 28 to 30 days. If reconstituted in unpreserved sterile water or PBS for immediate cell culture application, the solution should be used immediately or frozen into single-use aliquots at -80°C. Refrain from sub-zero storage of reconstituted liquid in standard non-frost-free freezers, as daily temperature cycles induce physical degradation.

Selecting the Correct Format: 60mg vs. Standard Catalog Mass

Choosing between a single 60mg high-capacity vial and multiple standard-sized vials (such as 2mg or 5mg) depends on research design and throughput requirements. High-throughput automated screening systems benefit from 60mg stock solutions by reducing vial swap-outs and minimizing batch variation across massive sample plates.

Conversely, small-scale pilot studies or single-cohort rodent experiments are generally better served by standard 2mg or 5mg vials available directly on our ipamorelin product page. Smaller formats eliminate the risk of long-term aqueous solution degradation and prevent waste if assay parameters shift mid-study. Research teams requiring specialized bulk manufacturing or large-scale lot reservations can review custom options via our wholesale portal.